An economic assessment of losartan-based versus atenolol-based therapy in patients with hypertension and left-ventricular hypertrophy: Results from the losartan intervention for endpoint reduction (LIFE) study adapted to The Netherlands

✍ Scribed by Cornelis Boersma; George W. Carides; Jarir Atthobari; Adriaan A. Voors; Maarten J. Postma

• Book ID: 116371979
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 742 KB
• Volume: 29
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/j.clinthera.2007.05.014